QNRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Quoin Pharmaceuticals Ltd (QNRX) is not a strong buy at this moment for a beginner, long-term investor with $50,000-$100,000 available. The lack of significant positive catalysts, weak financial performance, and no clear technical signals suggest holding off on investment for now.
The MACD is slightly positive but contracting, indicating weakening momentum. RSI is neutral at 48.79, showing no clear overbought or oversold condition. Moving averages are converging, and the stock is trading near its support level of 8.033, with resistance at 9.009. Overall, no strong technical buy signals are present.
NULL identified. No recent news or significant insider/hedge fund activity. The financials show a YoY improvement in net income, but this is still negative.
EPS dropped significantly by -58.81% YoY. Gross margin and revenue remain at zero. No recent congress trading data or influential figure activity. The company has a low market cap of $13.75M, indicating high risk.
In Q3 2025, revenue and gross margin remained at zero. Net income improved YoY but is still negative at -$3,948,165. EPS dropped significantly to -6.71, down -58.81% YoY, highlighting weak financial health.
No data available for analyst ratings or price target changes.
